Cellectis (CLLS) Research & Development: 2013-2022
Historic Research & Development for Cellectis (CLLS) over the last 10 years, with Dec 2022 value amounting to -$97.5 million.
- Cellectis' Research & Development rose 19.98% to -$19.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$84.1 million, marking a year-over-year increase of 20.34%. This contributed to the annual value of -$97.5 million for FY2022, which is 17.26% up from last year.
- As of FY2022, Cellectis' Research & Development stood at -$97.5 million, which was up 17.26% from -$117.8 million recorded in FY2021.
- In the past 5 years, Cellectis' Research & Development registered a high of $76.6 million during FY2018, and its lowest value of -$117.8 million during FY2021.
- In the last 3 years, Cellectis' Research & Development had a median value of -$97.5 million in 2022 and averaged -$100.8 million.
- In the last 5 years, Cellectis' Research & Development tumbled by 220.21% in 2019 and then grew by 17.26% in 2022.
- Cellectis' Research & Development (Yearly) stood at $76.6 million in 2018, then crashed by 220.21% to -$92.0 million in 2019, then grew by 5.53% to -$87.0 million in 2020, then slumped by 35.53% to -$117.8 million in 2021, then rose by 17.26% to -$97.5 million in 2022.